Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sumida

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Journal of Virology|July 15, 2005
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityAngelique A C Lemckert, Shawn M Sumida, Lennart Holterman, et al.
Journal of Virology|March 3, 2004
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectorsShawn M Sumida, Diana M Truitt, Michael G Kishko, et al.
Journal of Virology|October 29, 2005
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeysAnjali Nanda, Diana M Lynch, Jaap Goudsmit, et al.
Journal of Medicinal Chemistry|July 4, 1997
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymaseS Niwata, H Fukami, M Sumida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804Beryl McCormick, Kathryn A Winter, Wendy Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida, Diana M Truitt, Angelique A C Lemckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityDan H Barouch, Maria G Pau, Jerome H H V Custers, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|November 28, 2015
Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' projectN Adachi, V Adamovitch, Y Adjovi, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Journal of Virology|July 15, 2005
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityAngelique A C Lemckert, Shawn M Sumida, Lennart Holterman, et al.
Journal of Virology|March 3, 2004
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectorsShawn M Sumida, Diana M Truitt, Michael G Kishko, et al.
Journal of Virology|October 29, 2005
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeysAnjali Nanda, Diana M Lynch, Jaap Goudsmit, et al.
Journal of Medicinal Chemistry|July 4, 1997
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymaseS Niwata, H Fukami, M Sumida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804Beryl McCormick, Kathryn A Winter, Wendy Woodward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida, Diana M Truitt, Angelique A C Lemckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityDan H Barouch, Maria G Pau, Jerome H H V Custers, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|November 28, 2015
Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' projectN Adachi, V Adamovitch, Y Adjovi, et al.
Pageof 19